Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.
Systemic administration of cystamine is known to protect from both chemical and genetic models of neurotoxicity. Despite positive effects in laboratory models, cystamine has not been successfully translated to clinical application for neurodegenerative disease. Furthermore, the long held assumption that cystamine protects through tissue transglutaminase inhibition has recently been challenged. The studies described here examine other potential mechanisms of cystamine-mediated protection in an attempt to reveal molecular targets for neurodegenerative therapy. Based on previously described effects of cystamine, we examined the potential for activation of NF-E2 related factor 2 (Nrf2) mediated signaling through the antioxidant response element (ARE). We found that cystamine activates Nrf2/ARE both in cell culture and in brain tissue and then probed the mechanism of activation in cell culture. In live animals, we show that neuroprotection from 3-nitropropionic acid (3NP) toxicity is Nrf2-dependent. Therefore, these findings provide strong evidence that Nrf2 signaling may be an effective target for prevention of neurodegeneration.
Calkins
Marcus J
MJ
Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, WI, USA.
Townsend
Jessica A
JA
Johnson
Delinda A
DA
Johnson
Jeffrey A
JA
D000818:Animals; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D003538:Cystamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005455:Fluorescent Antibody Technique; D005978:Glutathione / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D051267:NF-E2-Related Factor 2 / Q000378:metabolism*; D009457:Neuroglia / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology; D009574:Nitro Compounds; D018384:Oxidative Stress / Q000187:drug effects; D011422:Propionates; D015398:Signal Transduction / Q000187:drug effects
D051267:NF-E2-Related Factor 2; D018696:Neuroprotective Agents; D009574:Nitro Compounds; D011422:Propionates; D005978:Glutathione; C015392:3-nitropropionic acid; D003538:Cystamine
Neurobiol Aging. 2006 Jun;27(6):862-70
15913845
J Biol Chem. 2003 Sep 26;278(39):37948-56
12842875
Free Radic Biol Med. 2008 Mar 15;44(6):1088-96
18206125
J Neurosci. 2005 Nov 2;25(44):10321-35
16267240
J Biol Chem. 2003 Feb 7;278(6):3825-30
12458211
J Neurosci. 2003 Apr 15;23(8):3394-406
12716947
J Neurosci. 2004 Feb 4;24(5):1101-12
14762128
J Neurochem. 2002 Jun;81(6):1233-41
12068071
Food Chem Toxicol. 2009 Oct;47(10):2522-30
19616597
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13943-8
8943040
Toxicol Appl Pharmacol. 1998 Jan;148(1):1-6
9465257
Nat Med. 2002 Feb;8(2):143-9
11821898
Biochem Biophys Res Commun. 2001 Jan 12;280(1):286-92
11162512
Am J Pathol. 2001 Oct;159(4):1507-20
11583977
Ann N Y Acad Sci. 2008 Dec;1147:61-9
19076431
J Neurochem. 2005 Aug;94(4):1087-101
15992377
Methods Mol Biol. 2008;477:229-43
19082951
Biochem Biophys Res Commun. 2005 Jan 14;326(2):371-7
15582588
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):244-9
15611470
Mol Cell Biochem. 1984;58(1-2):9-35
6143256
J Biol Chem. 2005 Jun 17;280(24):22925-36
15840590
Brain Res. 2007 May 4;1144:192-201
17336276
J Neurosci. 2008 Dec 10;28(50):13574-81
19074031
Antioxid Redox Signal. 2009 Mar;11(3):497-508
18717629
J Neurosci. 2002 Oct 15;22(20):8942-50
12388601
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2933-8
19196989
Brain Res. 2009 Jan 16;1249:229-36
19007756
Neurotoxicology. 2006 Dec;27(6):1094-100
16959318
Free Radic Biol Med. 2004 May 15;36(10):1208-13
15110385
J Clin Invest. 2006 May;116(5):1410-24
16604191
J Neurochem. 2008 Feb;104(4):1116-31
17995931
J Neurochem. 2005 Oct;95(1):210-20
16181425
J Neurosci Res. 2005 Feb 15;79(4):509-21
15641110
J Neurochem. 2009 Jun;109(5):1427-39
19476553
Neurosci Res. 2009 Apr;63(4):302-14
19367792
J Clin Invest. 1976 Jul;58(1):180-9
932205
Biochim Biophys Acta. 2008 Mar;1782(3):151-62
18206128
Stroke. 2007 Dec;38(12):3280-6
17962605
J Neuropathol Exp Neurol. 2007 Jan;66(1):75-85
17204939
Hepatology. 2006 Mar;43(3):454-63
16496303
Neurobiol Aging. 2006 Jun;27(6):871-9
15896882
Toxicol Sci. 2005 Sep;87(1):176-86
15976186
J Biol Chem. 1978 Apr 25;253(8):2615-23
24639
J Neurol Sci. 2005 Apr 15;231(1-2):57-66
15792822
Anal Biochem. 1969 Mar;27(3):502-22
4388022
Am J Physiol. 1989 Oct;257(4 Pt 1):L163-73
2572174
J Neurosci. 2007 Sep 19;27(38):10240-8
17881530
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):768-73
16407140
J Neurochem. 2004 Oct;91(2):413-22
15447674
Mutat Res. 2008 Jul-Aug;659(1-2):31-9
18164232
J Neurochem. 2006 Sep;98(6):1852-65
16945104
J Neurochem. 2000 Oct;75(4):1709-15
10987854